Frontlight ResearchEarly access
Trial site
Oslo Universitetssykehus
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease2 trials
- Ulcerative colitis2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Hepatitis B1 trial
- Hepatitis C1 trial
- HIV1 trial
- Kidney cancer1 trial
- Neuroblastoma1 trial
- Phase
- Phase 34 trials
- Phase 41 trial
- Status
- Completed4 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Incyte Corporation2 trials
- Copenhagen University Hospital, Rigshospitalet1 trial
- Institut Curie1 trial
- Karolinska University Hospital1 trial
- Region Örebro County1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial
Enrolling by invitation
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Hepatitis B1 recruiting
- Hepatitis C1 recruiting
- HIV1 recruiting
- Neuroblastoma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Site data: ClinicalTrials.govUpdated 12 Nov 2026